DEA Controlled Substance Prescribing via Telehealth: Navigating the Ryan Haight Act and Post-PHE Regulations

The landscape of prescribing controlled substances via telehealth, especially across state lines, is a complex and highly regulated area. At its core, federal law, primarily the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, dictates the conditions under which controlled substances can be prescribed using telemedicine. This act generally requires an initial in-person medical evaluation before a practitioner can prescribe controlled substances to a patient via an online or telemedicine encounter. However, the COVID-19 Public Health Emergency (PHE) introduced temporary flexibilities that significantly altered this requirement, and the Drug Enforcement Administration (DEA) is now working to establish permanent rules for the post-PHE era.

The Ryan Haight Act: Foundation of Telehealth Prescribing for Controlled Substances

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (21 U.S.C. § 829(e)) was enacted to combat the proliferation of